A process for producing optically active (R)-3-hydroxybutyrate and (R)-3-hydroxyvalerate mixtures, where the ratio between them is defined by the composition of PHB-co-HV, used as raw material for the production process, formulations containing the mixtures, and uses of the formulations. A use or method of treating a subject having a metabolic disorder, comprising administering optically active mixtures of (R)-3-hydroxybutyrate and (R)-3-hydroxyvalerate, their respective salts or esters derived therefrom, obtained according to the process of the present disclosure at a therapeutically effective amount to treat at least one symptom of the metabolic disorder.

A peanut food product with reduced levels of allergenic proteins such as Ala h1/h2/h3 is produced by initiating the germination process in raw peanuts, holding the peanuts in moist conditions to initiate germination, and then treating with bromelain.

Compositions containing bromelain are disclosed for use as topical therapeutic agents for the treatment of rosacea. The compositions include lotions, creams and ointments.

Compositions containing bromelain are disclosed for use as topical therapeutic agents for the treatment of dermal itch. The compositions include lotions, creams and ointments.

Compositions containing bromelain are disclosed for use as topical therapeutic agents for the treatment of eczema. The compositions include lotions, creams and ointments.

A combination of Arnica montana extract, bromelain, Calendula extract, daisy flower extract, grape seed extract, copper, and zinc for topical use that regulates skin immunomodulation.

A peanut food product with reduced levels of allergenic proteins such as Ala h1/h2/h3 is produced by initiating the germination process in raw peanuts, holding the peanuts in moist conditions to initiate germination and then treating with bromelain.

The present invention relates to novel compositions comprising proteolytic enzymes and fining agents as well as methods for the treatment and/or prevention of cancer using these compositions.

Compositions and methods are provided to destroy internal cancerous lesions selectively by the administration of a combination of a debridement protease enzyme and a denaturant of cell structural proteins and or cell adhesion proteins.

Some aspects described herein provide power and liquid compositions, which may be utilized for dental care. Some aspects provide small grained compositions that include activated carbon with small particle size, which may be used for dental care. One aspect includes a dental cleaning powder. For example, the dental cleaning powder includes activated carbon. For example, the activated carbon may have a D90 particle size of between approximately 25 m and approximately 45 m. Another aspect includes a method for air polishing, which includes injecting to an oral cavity an aqueous solution of one or more water-soluble enzymes via a liquid compartment of an air polishing device.